Clostridium botulinum is a taxonomic designation that encompasses a broad variety of spore-forming, Gram-positive bacteria producing the botulinum neurotoxin (BoNT). C. botulinum is the etiologic agent of botulism, a rare but severe neuroparalytic disease. Fine-resolution genetic characterization of C. botulinum isolates of any BoNT type is relevant for both epidemiological studies and forensic microbiology. A 10-locus multiple-locus variable-number tandem-repeat analysis (MLVA) was previously applied to isolates of C. botulinum type A. The present study includes five additional loci designed to better address proteolytic B and F serotypes. We investigated 79 C. botulinum group I strains isolated from human and food samples in several European countries, including types A (28), B (36), AB (4), and F (11) strains, and 5 nontoxic Clostridium sporogenes. Additional data were deduced from in silico analysis of 10 available fully sequenced genomes. This 15-locus MLVA (MLVA-15) scheme identified 86 distinct genotypes that clustered consistently with the results of amplified fragment length polymorphism (AFLP) and MLVA genotyping in previous reports. An MLVA-7 scheme, a subset of the MLVA-15, performed on a lab-on-a-chip device using a nonfluorescent subset of primers, is also proposed as a first-line assay. The phylogenetic grouping obtained with the MLVA-7 does not differ significantly from that generated by the MLVA-15. To our knowledge, this report is the first to analyze genetic variability among all of the C. botulinum group I serotypes by MLVA. Our data provide new insights into the genetic variability of group I C. botulinum isolates worldwide and demonstrate that this group is genetically highly diverse.
The Clostridium botulinum taxon constitutes a polyphyletic cluster of anaerobic Gram-positive spore-forming species which share the feature of producing the dangerous botulinum neurotoxin (BoNT). BoNT is the etiological agent of botulism, a rare but severe neuroparalytic disease recognized in four natural forms (food-borne botulism, wound botulism, infant botulism, and adult intestinal colonization botulism) (15) .
A historical subdivision of C. botulinum into four groups (I to IV) has been made on the basis of biochemical and biophysical criteria (fermentative and proteolytic capabilities, metabolic acids, spore heat resistance, optimal growth temperature, etc.) (4, 21) .
On the basis of the toxin antigenic specificity of BoNT, C.
botulinum strains are divided into seven serotypes (A to G) (4, 21) . Serotypes A, B, E, and, rarely, F are responsible for human botulism cases. Cases associated with C and D serotypes are observed mainly in animals. No botulism cases linked to serotype G have been reported (1, 15) . Group I includes serotype A strains and the proteolytic B and F strains. Group II includes all E serotype strains and the nonproteolytic B and F strains. Group III encompasses serotype C and D strains, while group IV is only composed of serotype G strains (4, 21) . Differences in the BoNT gene nucleotide sequences lead to the definition of five subtypes (A1 to A5) for type A, five (proteolytic B1 to B3, bivalent B, and nonproteolytic B) for type B, four (E1 to E3 and E6) for type E, and seven (F1 to F7) for type F (2, 3, 6, 23) . Two subtypes from BoNT/E-producing Clostridium butyricum strains (subtypes E4 and E5) have been described (3) . Usually C. botulinum strains produce only a single serotype of BoNT, but "bivalent" strains producing two different serotypes of BoNT have been isolated (20, 21) . Smallsubunit rRNA (16S rRNA) sequence analysis has shown that C. botulinum is a taxonomic designation comprising diverse species of anaerobic spore-forming bacteria. Moreover, ribotyping has shown that the phenotypic groups correspond to genotypic units (4, 10, 26) . rRNA 16S sequencing has also demonstrated that some groups of non-BoNT-producing clostridia, classified by current taxonomy as distinct species (Clostridium sporogenes, Clostridium novyi, Clostridium proteolyticus, and others), are indeed encompassed in one of four C. botulinum groups. In particular, C. sporogenes appears to be related to group I (10) . So far, several genotyping methods have been applied to C. botulinum strains for taxonomic, molecular epidemiology, and forensic purposes: pulsed-field gel electrophoresis (PFGE) (9, 18) , amplified fragment length polymorphism (AFLP) (10, 14, 17) , multilocus sequence typing (MLST) (13) , and whole-genome DNA microarrays (2) . The clustering of populations using these genotyping methods is only partially congruent with BoNT gene lineage, suggesting that BoNT genes have evolved separately from the bacterial chromosome through horizontal genetic transfer events (2, 4, 8, 10, 11) . This hypothesis is supported by the discovery, in some C. botulinum strains, of transposable insertion sequences (IS) close to the BoNT genes and of BoNT gene sequences in plasmids (8, 24, 25, 29) .
The reliability of multilocus variable-number tandem-repeat (VNTR) analysis (MLVA) for high-resolution genotyping has already been shown for many pathogens (28, 22) . A recent study highlighted the discrimination capability of a 10-locus MLVA (MLVA-10) scheme among C. botulinum serotype A strains (17) .
High-resolution genetic characterization of C. botulinum strains still remains a challenge for epidemiological studies, as well as for forensic microbiology. In the past, some countries or terrorist groups were believed to have developed research programs evaluating BoNT as a biological weapon (1) . These are reasons why additional efforts to improve MLVA capabilities are needed.
The aims of the present study are the improvement of genetic discrimination among group I C. botulinum strains and the setting up of an internet-based MLVA database useful in a terrorist attack, as well as in botulism outbreaks in human and wildlife. New VNTR markers were developed to better define genetic clustering among group I C. botulinum isolates (types A, B, bivalent, and F).
MATERIALS AND METHODS

Strains.
The 79 C. botulinum and 5 C. sporogenes strains examined in this study (Table 1) were provided by the Division of Analytical Microbiology, DGA CBRN Defense (Vert-Le-Petit, France), Bundeswehr Institute of Microbiology (Munich, Germany), Georg-August-University of Goettingen (Goettingen, Germany), Thueringer Landesamt für Lebensmittelsicherheit und Verbraucherschutz (Bad Langensalza, Germany), TNO Defense, Security, and Safety (Rijswijk, The Netherlands), Norwegian Defense Research Establishment, Division for Protection, (Kjeller, Norway), and National Reference Center for Botulism, Department of Veterinary Public Health and Food Safety, Istituto Superiore di Sanità (Rome, Italy). DNA was extracted by heating culture supernatants with Chelex resin solution at 95°C (7) or by cell lysis, followed by phenol-chloroform extraction and ethanol precipitation.
All strains were submitted to 16S rRNA gene analysis. Moreover, the 40 Italian strains were submitted to sugar fermentation and proteolytic activity tests. All of the C. botulinum strains belong to group I; 28 are BoNT/A strains, 36 BoNT/B, 4 BoNT/AB, and 11 BoNT/F ( Fig. 1 ). In addition, five non-toxinproducing C. sporogenes strains were included to complete the C. botulinum group I genotypes.
All strains were from different botulism events, and no isolates were associated with one another.
The collection analyzed in this study includes clinical and food isolates, as well as reference strains whose whole-genome sequence data have been made public (Table 1) . Their geographical origins include European (Italy, France, Germany, United Kingdom, Norway, and Spain) and non-European countries (New Zealand, United States, and Japan).
VNTR identification. By using the Microbial Tandem Repeats database (http: //minisatellites.u-psud.fr) (5) on the Hall strain sequence (GenBank accession number NC_009698), 57 potential VNTR loci were detected, including 10 previously investigated by Macdonald and colleagues (17) . Nine loci that have not been investigated previously were evaluated. Five were selected ( Table 2) . Consequently, a pool of 15 VNTR loci is now available to define an MLVA typing panel. For the 10 previously published VNTR loci, except for cbms10 (Clostridium botulinum mini satellite 10), new primers were designed, closer to the VNTR region than previous ones, for the purpose of optimizing allele sizes ( Table 2 ). The primers were synthesized with a fluorescent Cy5.5 or Cy5 label on the forward primer (Eurofins MWJ, Edersberg, Germany).
VNTR amplification and fragment separation. Amplification was performed in seven duplex PCRs (cbms1-cbms11, cbms02-cbms08, cbms03-cbms04, cbms05-cbms12, cbms06-cbms14, cbms07-cbms15, and cbms10-cbms13) and a singleplex PCR (cbms09).
The PCR amplifications were performed in a final volume of 15 l containing 1ϫ PCR buffer (10 mM Tris-HCl, 1.5 mM MgCl 2 , 50 mM KCl, pH 8.3), 0.2 mM deoxynucleoside triphosphates (dNTPs), 0.2 M labeled forward and reverse primers, 1 U Taq polymerase, and 1 ng of template DNA. Identical thermocycling conditions were used for all VNTR assays, as follows: an initial denaturation at 95°C for 3 min, followed by 35 cycles of 95°C for 30 s, 55°C for 30 s, 72°C for 1 min, followed by a final elongation step at 72°C for 5 min. PCR products were diluted 1:5 in water, and then 1-l amounts were sized on a CEQ 8000 DNA sequencer (Beckman Coulter, Brea, CA) using 0.7 l of MapMarker 1000 molecular-weight markers (BioVenture, Murfreesboro, TN) as described in Lista et al. (16) . A comparison between expected and observed product sizes using the CEQ 8000 may be found in file S1 in the supplemental material.
All 15 loci were also amplified with unlabeled primers in singleplex assays, and amplicons were measured on a lab-on-a-chip Agilent 2100 bioanalyzer (Agilent Technologies, Santa Clara, CA). A comparison between observed and expected product sizes using the Agilent 2100 Bioanalyzer software may be found in file S2 in the supplemental material.
Sequencing analysis. Some representative PCR fragments resulting from VNTR amplifications were sequenced to verify fragment length and the corresponding number of repeat units (RU) (data not shown).
The PCR amplicons were purified and sequenced with a CEQ 8000 automatic DNA analysis system (Beckman Coulter, Fullerton, CA), using a commercial kit (GenomeLab DTCS [dye terminator cycle sequencing] quick start kit; Beckman Coulter) according to the manufacturer's instructions.
In order to confirm that all 84 samples used in this study belong to group I, 16S rRNA gene sequencing was performed (data available on request). Primers 27F (AGAGTTTGATCMTGGCTCAG) and 1492R (GGTTACCTTGTTACGA CTT) were used to amplify approximately 1,400 bases of this 1.5-kb gene. Then, the amplicons were purified using NucleoSpin extract II (Macherey-Nagel, Duren, Germany) and sequenced using the same primers (Genechron, Rome, Italy). The 16S rRNA gene phylogenetic dendrogram was created from an alignment of 16S rRNA gene sequences, some original from this study and others obtained from GenBank. Sequence data were imported into BioNumerics (version 6.5) (Applied Maths, Sint-Martens-Latem, Belgium) and aligned in a multiple alignment, and a dendrogram was calculated using the unweighted-pair group method with arithmetic mean (UPGMA) clustering algorithm ( Fig. 1) .
VNTR genotyping. Observed sizes were converted to repeat copy number by a macro (Openoffice Calc 3.2 by Oracle) developed by the Lista group (available on request to F.L.).
VNTR repeat unit profiles obtained from 15 loci were imported into Bio-Numerics version 6.5 (Applied Math, Sint-Martens-Latem, Belgium) as character values, and dendrograms were calculated using the categorical coefficient and the UPGMA clustering algorithm. A dendrogram was generated for the complete panel (MLVA-15) and also for two subsets: MLVA-10, including only previously published loci, and MLVA-7, including loci considered suitable for lab-on-a-chip analysis.
To better standardize the allele calling, the following C. botulinum group I genome sequences were also included in the analysis, using in silico analysis to deduce their MLVA data: ATCC 3502 A1 (GenBank accession number NC_009495), ATCC 19397 A1 (NC_009697), Hall A1 (NC_009698), Kyoto A2 (NC_012563), Loch Maree A3 (NC_010520), bivalent 657 BA4 (NC_012658), Okra B1 (NC_010516), Langeland F (NC_009699), H04402 065 A5/B3 (CP002011), and F strain 230613 (FR773526). (7, 8, 13 , and 15 RU) were observed for cbms05; three new alleles (3, 3.5, and 5 RU) were observed for cbms07; one new allele (2 RU) was observed for cbms11; and four new alleles (3, 10, 11, and 12 RU) were observed for cbms14.
The amplification of several VNTR loci resulted in "intermediate" allele fragment sizes (Table 3) , probably due to insertions and/or deletions occurring outside or even within the repeat unit sequence, as observed in fully sequenced genomes. In cbms03, the intermediate allele, 12.5 RU, is the result of a 5-bp insertion located in the 5Ј VNTR flanking region (data not shown). Moreover, some cbms03 fragments showed a shorter length than the 1-RU allele expected size. Most likely, as observed in the fully sequenced Langeland (NC_009699) and Loch Maree genomes (NC_010520), large deletions are scattered over this locus.
Locus cbms10, alias VNTR6 (17) (18-bp RU), is characterized by deletions/insertions in the 5Ј and 3Ј repeat regions, as shown by the comparison of eight fully sequenced strains (Table 4). Although the RU is 18 bp long, the resulting observed differences between fragment sizes mimic a 6-bp repeat unit variation. These data suggest that, for convenience, cbms10 could be considered a hexamer.
Clustering of strains. Analysis of 94 strains by use of the MLVA-15 scheme (84 analyzed strains plus 10 typed by in silico analysis) resulted in 86 genotypes with a Hunter and Gaston index of diversity (HGDI) (12) of 0.998.
The genotypes are distributed in seven main groups (Fig. 2 ) and 28 isolated strains (cluster cutoff value, 50%). Among the main groups, one, the "F group," contains nine strains, including the Langeland and 230613 F strains (cluster 1). Three groups are composed of serotype B strains only-the "B1 Okra group" (cluster 2), comprising Okra together with seven strains mainly originating from Northern Europe, and the "first Italian B group" (cluster 3) and "second Italian B group" (cluster 4) with seven and five strains, respectively, all originating from Italy. Two groups contain exclusively serotype A-the "A2 Kyoto group" (cluster 5), which contains the Kyoto strain plus eight serotype A strains, mainly A2, coming from Italy, and the "A1 ATCC 3502 group" (cluster 6) with 13 members, in which the ATCC 3502 A1, ATCC 19397 A1, and Hall A1 strains were included. One group contains different serotypes, being composed of both A and B members, i.e., the "A/B group" (cluster 7) with strains originating from Italy and France.
Twenty-eight strains appear to be genetically distinct from the seven established clusters.
MLVA-10 and MLVA-7 generated 82 and 52 distinct genotypes, respectively, with HGDI values of 0.996 and 0.971. 1. UPGMA dendrogram generated by multiple alignment of rRNA 16S genes. To classify strains analyzed in the present report into groups I to IV, their rRNA 16S gene sequences were compared to available sequences of isolates from the four groups in GenBank. Table 4 Hypothetical protein cbms1 cbms2 cbms3 cbms4 cbms5 cbms6 cbms7 cbms8 cbms9 cbms10 cbms11 cbms12 cbms13 cbms14 cbms15   45  8  12  1  8  11  2  3.5  6  4  31  2  1  23  7  3  46  10  6  6  16  13  2  4  10  4  23  3  1  18  6  4  50  5  14  12  7  12  2  2  5  3  17  1  1  23  11  5  53  11  11  del4  7  10  2  2  5.5  4  28  2  3  17  9  3  75  5  11  3  21  13  2  4  6  4  33  1  3  24  8  3  79  10  8  2  21  12  2  3.5  6  3  17  3  1  28  9  3  81  5  6  8  7  12  2  2  5  3  17  1  1  23  7  5  85  8  12  13.5  8  9  1  4  6  4  28  2  1  23  6  3  87  8  12  13.5  8  9  1  4  6  4  28  2  1  23  6  3  92  11  12  13 4  41  3  6  3  3  14  7  4  2/5  6  10  13  29  5  2  4  10  3  27  3  3  22  7  4  4/5  9  10  5  21  5  2  4  10  4  27  3  3  22  7  4  5/5  9  10  5  21  5  2  4  6  4  27  3  3  22  7  4  CEB06128  6  10  14  14  10  1  4  6  2  17  1  1  21  7  2  CEB06129  8  10  9  16  5  2  4  10  4  27  3  3  22  7  4  CEB06173  7  12  21.5  17  12  2  4  6  4  31  2  1  23  12  3  CEB06173  10  12  2  14  12  2  3.5  6  3  59  3  1  22  9  3  31  12  4  9  25  10  1  4  7  3  30  3  3  23  9  4  9 0  7  1 4  1 6  3 1  1 1  2  2  5  3  1 5  1  1  2 3  1 1  5  103  9  10  2  15  12  2  3.5  6  3  17  3  1  29.5  9  3  127  9  6  2  21  12  2  3.5  6  3  17  3  1  28  9  3  172  8  6  6  18  13  2  4  10  4  23  3  1  18  6  4  173  14  14  3  1  9  2  3.5  6  4  28  2  1  23  6  3  181  9  10  9  11  11  2  4  6  4  24  2  3  21  9  4  186  9  10  2  14  12  2  3.5  6  3  17  3  1  28  9  3  261  13  15  del4  26  13  2  3  9  4  26  1  3  19  11  5  2 6 7  6  1 2  1 1  1 6  1 1  2  3  6  2  1 7  1  1  2 3  7  3  275  6  10  8  23  11  2  5  6  4  32  1  3  20  9  34  331  5.5  14  12  18  11  2  2  5  3  15  1  1  23  11  5  341  5  14  7  8  12  2  2  5  3  17  1  1  23  7  5  361  12  14  3  1  9  2  3.5  6  4  28  2  1  23  6  3  363  9  4  2  22  12  2  3.5  6  3  17  3  1  28  9  3  380  9  4  14  7  10  1  3.5  7  3  30  3  3  29  9  4  386  5  4  3  9  12  2  3  6  2  20  1  1  19  8  3  389  8  11  2  11  12  2  4  6  4  28  2  1  23  8  3  390  8  12  1  8  11  2  3.5  6  4  31  2  1  23  7  3  4 0 1  5  1 0  1 6  1 2  1 1  2  4  6  4  2 4  2  3  2 1  9  4  413  9  6  14  34  8  2  4  6  2  20  2  1  23  8  3  433  9  10  5  13  9  2  4  6  4  23  2  3  26  9  4  128  11  10  19  17  9  2  4  6  4  24  2  3  21  8  5  BM270  7  10  5  7  11  2  4  6  2  34  3  1  23  6  3  BM271  7  10  13  21  5  2  4  10  3  27  3  3  22  7  4  BM277  9  9  del5  12  15  2  3.5  5.5  3  27  1  1  21  8  3  BM278  9  10  5  21  5  2  4  10  4  27  3  3  22  7  4  BM279  5  8  7  13  8  1  3.5  5.5  2  24  1  1  23  7  4  BM291  6  12  12  13  9  2  5  5.5  3  25.5  1  1  17  10  3  CIP104310T  8  10  9  15  5  2  4  10  4  27  3  3  22  7  4  CIP104312  7  9  13  21  15  2  3.5  5.5  3  28  1  1  21  8  3  CIP60.10  8.5  9  5  21  15  1  4  16  3  5  1  3  22  8  7  CB745  10  10  del5  12  11  2  5  7  3  25  2  1  14  3  4  A2  7  9  del5  12  15  2  3.5  5.5  3  28  1  1  21  8  3  IBT 2268  7  10  5  7  12  2  4  6  2  34  3  1  23  6  3  IBT 2295  9  10  16  18  5  2  4  9  4  27.5  3  3  24  8  4 Continued on following page 
DISCUSSION
Genetic characterization of C. botulinum neurotoxin-producing strains is a challenging issue because of the great variability not only of toxin types and subtypes but of their host genetic background. Different genotyping methods, PFGE, AFLP, MLST, and MLVA, are suitable for epidemiological studies and forensic discrimination. Each one of these techniques shows advantages and limitations. PFGE and AFLP are more difficult to standardize among different laboratories because they produce patterns which cannot be conveniently coded. MLST, possibly the most informative method, appears to be more time consuming and difficult to perform. MLVA is easier to perform and less time consuming than MSLT and can be more easily standardized by different laboratories than AFLP and PFGE.
In the present study, in order to include all of the C. botulinum group I serotypes (A, B, F, and bivalent) and gain higher discriminating power and clustering robustness, we propose to introduce five new loci, resulting in an MLVA-15 scheme.
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on March 20, 2014 by 92370268 http://jcm.asm.org/ mainly to C. botulinum serotype A strains because, for the other subtypes analyzed (B to G), VNTR primers amplified only a few loci or the PCR products were not of the expected size (17) . The amplification failure observed for most of the loci was probably due to the mutations within the primer binding sites. In silico analysis on fully sequenced genomes indicates the conservation of the primer sequences not only in A strains but also in B Okra and F Langeland (group I) strains (11, 17) . In contrast, the selected primers for the 15 loci fail to match on the complete genomes of group II isolates (B Eklund and E3 Alaska), suggesting that these 15 loci are absent or highly mutated in C. botulinum group II strains. This finding further supports the idea that group I and group II species are well separated (4, 11, 26) .
Eighty-nine C. botulinum strains analysis using MLVA-15 determined seven main clusters. Six of these clusters are char- http://jcm.asm.org/ acterized by homogeneity of toxin serotype (Fig. 2) . Preliminary data from MLST (gyrase B, adenylate kinase, and transcription factor A, approximately 350 to 400 bp) performed in clusters 1, 2, and 6 confirm the genetic homogeneity of these clusters.
Most group I C. botulinum type B strains are represented in three distinct clusters (2, 3, and 4), one of which (group 4) appears genetically very distant from the other two B clusters. Cluster 6 (A1 subtypes) is closer to group 4 (B) than to the A2-producing group. Among serotype F strains, Reb 1955 appears very divergent from all other strains. This is a confirmation of previous studies that show a lack of congruence between the phylogenies of toxin genes and other chromosomal genes (4, 10, 11) . A possible explanation could be horizontal gene transfer, a phenomenon already well known in different bacterial species, sometimes involving virulence factors (19) . In support of this hypothesis, IS elements were discovered in the flanking regions of the BoNT gene in some genomes and/or the BoNT gene was found in plasmids in some C. botulinum strains. IS elements and plasmids are involved in the mobilization of DNA sequences among different strains (8, 11, 24, 25, 29) . IS elements allow the transfer of genes between chromosomes and plasmids, and plasmids can mediate the exchange of genetic material between individuals (27) .
C. sporogenes strains, as expected, show a genetic distribution far from C. botulinum cluster 7.
Comparing the MLVA results with the results of previous genotyping studies, there is a good accordance with AFLP (10, 14) and MLVA (17) results. In a C. botulinum AFLP study (14) , proteolytic F strains showed a single cluster, whereas both A and proteolytic B strains formed different clusters, not often strictly related with the same serotype clusters, as shown in the dendrogram in Fig. 2 . In a published MLVA report (17) , strains are divided into two main groups, one including A1 and A3 strains and the other A2 and bivalent A1(B) strains. The ATCC 3502 strain falls into the first group, and the Kyoto strain falls into the second. Although not all toxin subtypes have been determined for strains investigated here, it is possible to identify the similarities between the two dendrograms because nine strains are shared. The two main groups described by Macdonald et al. (17) could correspond, respectively, to the present A1 ATCC 3502 group and the A2 Kyoto group. In Fig. 2 , these two clusters represent two different main branches. This fact could be an element in favor of the phylogenetic reliability of the chosen MLVA-15 marker panel.
Even in the relatively limited and very diverse collection investigated here, an improvement of discrimination power is achieved by MLVA-15, since the HGDI values calculated for MLVA-10 and MLVA-15 were 0.996 and 0.998, respectively, which is an increase of 0.002 for the MLVA-15. MLVA-15 and MLVA-10 were also applied to a larger number of samples (up to 154 strains, data not shown), and in this case, the HGDI values were 0.991 and 0.986, which is a more evident increase (0.005). Moreover, in analyzing the cluster distribution with MLVA-10, two groups (3 and 7) are separated into further subgroups. From these observations, it can be concluded that the addition of five new loci determine a more compact and robust clustering (Fig. 3) .
We explored the possibility of transferring the MLVA-15 scheme to a less expensive, laborious, and time-consuming platform, either agarose gel or lab-on-a-chip. This would enhance its use in a wider range of laboratories. Only seven markers (cbms05, cbms06, cbms09, cbms11, cbms12, cbms14, and cbms15) were suitable for such platforms. This is due to the less accurate reproducibility of fragment sizing with these separation techniques. The lab-on-a-chip Agilent 2100 bioanalyzer platform is more suitable for rapid typing of small collections of samples and could provide a point-of-care or fieldcompatible assay.
A UPGMA analysis was calculated for this subpanel (MLVA-7) . The MLVA-7 dendrogram shows a clustering with few differences from that obtained using MLVA-15 (52 versus 86 profiles) ( Fig. 3) . The congruence between MLVA-15 and MLVA-7 as measured by UPGMA analysis, using BioNumerics version 6.5 with Pearson correlation, was 81.75. The MLVA-7 clustering tends to underestimate evolutive distances between groups, so at the cutoff chosen for MLVA-15 (50%), group 1, group 2, and group 3 are not separated. We conclude that MLVA-7 can be useful for discrimination at the cluster level but not at the strain level.
This study shows for the first time genetic variability among all of the C. botulinum group I serotypes by using a more refined and robust MLVA scheme. More-extended studies on a larger number of strains, coming from various geographic origins as well as encompassing a wider spectrum of neurotoxin subtypes, will be done in the future to gain new insights about the genetic diversity of C. botulinum worldwide.
